Table 1.
The clinical information of the patients
| Variants | Total [Cases (%)] |
CCT6A Expression [Cases (%)] | P value | |
|---|---|---|---|---|
| Low | High | |||
| Total | 80 | 28 | 52 | |
| Gender | ||||
| Male | 36 (45%) | 16 (57.14%) | 30 (57.69) | 0.999 |
| Female | 44 (55%) | 12 (42.86%) | 22 (42.14) | |
| Age at diagnosis | ||||
| >65 | 19 (23.75%) | 4 (14.29%) | 15 (28.85%) | 0.177 |
| ≤ 65 | 61 (76.25%) | 24 (85.71%) | 37 (71.15%) | |
| Pathology stage | ||||
| I |
19 (23.75%) |
9 (32.14%) |
8 (15.38%) |
0.078 |
| II |
23 (28.75%) |
11 (39.29%) |
14 (26.92%) |
|
| III |
24 (30%) |
6 (21.43%) |
19 (36.54%) |
|
| IV |
13 (16.25%) |
2 (7.14%) |
11 (21.15%) |
|
| Tumor size | ||||
| ≤ 3 cm |
20 (25%) |
13 (46.43%) |
12 (23.08) |
0.044 |
| >3 cm |
60 (75%) |
15 (53.57%) |
40 (76.92) |
|
| Lymph node metastasis | ||||
| Absent |
31 (38.75%) |
14 (50%) |
18 (34.62%) |
0.233 |
| Present |
49 (61.25%) |
14 (50%) |
34 (65.38%) |
|